Five postdoctoral research scientists and two associate research scientists who work in Columbia medical and dental school labs took home honors at this year’s Postdoctoral Research Symposium.
Ever since Type A personality was linked to cardiovascular disease in the 1950s, it’s been known that anger raises the risk of heart attack and stroke. Now a Columbia study may explain how.
Extended-release naltrexone initiated after just five to seven days of seeking treatment is more effective than starting treatment after the traditional interim stage of 10 to 15 days.
Columbia neuroscientists found that the mouse brain can direct the body's immune system to an unexpected degree, a discovery that could lead to new therapies for many immune disorders.
Twenty years ago, Columbia scientists created a way to make neurons in a dish, a discovery that has led to clinical trials of an experimental drug that may slow the progression of ALS.
Spontaneous errors in the earliest phase of cell division may explain why so many human embryos fail to develop normally, according to research from Columbia University.
Using EEG to identify covert consciousness in unresponsive brain-injured patients could help predict which ones may recover, find researchers at Columbia and NewYork-Presbyterian.
By analyzing thousands of genetic risk variants, a new algorithm developed by Columbia researchers may be able to predict your risk of developing chronic kidney disease decades before onset.
Using advanced imaging methods, researchers have gained insight into how a common target of drugs sends cellular signals, a finding that may lead to better and more precise therapeutics.
One of the most important molecules in the brain doesn’t work quite the way scientists thought it did, according to new work by researchers at Columbia and Carnegie Mellon.